Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
Immunology|March 29, 2014
Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblastsNatasja Nielsen, Veronique Pascal, Andreas E R Fasth, et al.
Arthritis and Rheumatism|May 28, 2011
Blockade of NKG2D ameliorates disease in mice with collagen-induced arthritis: a potential pathogenic role in chronic inflammatory arthritisAnna K Andersson, Percy F Sumariwalla, Fiona E McCann, et al.
Diabetes Care|January 26, 2023
Exocrine Proteins Including Trypsin(ogen) as a Key Biomarker in Type 1 DiabetesLilianna Bakinowska, Tanwi Vartak, Thato Phuthego, et al.
EMBO Molecular Medicine|March 16, 2015
Low-dose TNF augments fracture healing in normal and osteoporotic bone by up-regulating the innate immune responseJames K Chan, Graeme E Glass, Adel Ersek, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2020
Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolismAdam P Cribbs, Stefan Terlecki-Zaniewicz, Martin Philpott, et al.
Ebiomedicine|July 10, 2018
Anti-Tumour Necrosis Factor Therapy for Dupuytren's Disease: A Randomised Dose Response Proof of Concept Phase 2a Clinical TrialJagdeep Nanchahal, Catherine Ball, Dominique Davidson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2018
Glatiramer Acetate Enhances Myeloid-Derived Suppressor Cell Function via Recognition of Paired Ig-like Receptor BWilliam van der Touw, Kyeongah Kang, Yi Luan, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2004
Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritisYuhua Zhang, Jun Xu, Jeremy Levin, et al.
Science Immunology|September 18, 2020
Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19Elizabeth R Mann, Madhvi Menon, Sean Blandin Knight, et al.
Arthritis Research & Therapy|February 8, 2007
Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005Alan Tyndall, Ulrich A Walker, Andrew Cope, et al.
Pageof 15